Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

BridgeBio Pharma (BBIO) Shares Outstanding: 2019-2025

Historic Shares Outstanding for BridgeBio Pharma (BBIO) over the last 6 years, with Jun 2025 value amounting to $191.2 million.

  • BridgeBio Pharma's Shares Outstanding rose 1.66% to $191.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $191.2 million, marking a year-over-year increase of 1.66%. This contributed to the annual value of $190.0 million for FY2024, which is 8.55% up from last year.
  • Latest data reveals that BridgeBio Pharma reported Shares Outstanding of $191.2 million as of Q2 2025, which was up 0.70% from $189.8 million recorded in Q1 2025.
  • Over the past 5 years, BridgeBio Pharma's Shares Outstanding peaked at $191.2 million during Q2 2025, and registered a low of $147.1 million during Q3 2021.
  • Over the past 3 years, BridgeBio Pharma's median Shares Outstanding value was $187.6 million (recorded in 2024), while the average stood at $180.6 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first increased by 22.87% in 2021, then fell by 0.96% in 2022.
  • Quarterly analysis of 5 years shows BridgeBio Pharma's Shares Outstanding stood at $147.3 million in 2021, then grew by 2.23% to $150.6 million in 2022, then rose by 16.24% to $175.1 million in 2023, then increased by 8.55% to $190.0 million in 2024, then increased by 1.66% to $191.2 million in 2025.
  • Its Shares Outstanding stands at $191.2 million for Q2 2025, versus $189.8 million for Q1 2025 and $190.0 million for Q4 2024.